This podcast will help pathologists gain deeper skills in improving HER2 IHC testing in patients with breast cancer. and includes the following topics:
The activity offers 0.75 CME/CMLE credit.
Learning Objectives:
Upon completion of this activity, you should be able to:
Faculty:
Aysegul A Sahin, MD
Director of Educational Operations
Department of Pathology, Division of Pathology/Lab Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Ali Brown, MD, FASCP
Chief Officer, Medical Quality
American Society for Clinical Pathology
Washington, DC
Erin Downs-Kelly, DO
Director, Breast Pathology
Cleveland Clinic
Cleveland, OH
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this enduring material for a maximum of 0.75 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Provided by the American Society for Clinical Pathology in partnership with Q-Synthesis, LLC and Clinical Care Options, LLC.
Funded by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.